Latest updates for Glaxf

Fresh curated links around GLAXF are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
  • Vinyl Group Ltd (JAXAF) Vinyl Group Ltd, - M&A Call - Slideshow
  • <![CDATA[GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc. ]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript

Read source
seekingalpha.com /4 weeks ago

Vinyl Group Ltd (JAXAF) Vinyl Group Ltd, - M&amp;A Call - Slideshow

Read source
pharmexec.com /1 month ago

&lt;![CDATA[GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc. ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion]]&gt;

Read source
seekingalpha.com /1 week ago

Gold Mid-Year Outlook 2026: Point Break

Read source
seekingalpha.com /3 weeks ago

Goldman Sachs Large Cap Growth Insights Fund Q1 2026 Commentary

Read source
seekingalpha.com /1 month ago

GSK: Improved Prospects After Correction

Read source
seekingalpha.com /1 month ago

Astellas Pharma Inc. (ALPMY) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Glaxf

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source